Tumor Immunotherapy
Targeted Cancer Therapies
Cytotoxic T Cells-mediated Immune Response
Cell-mediated Immune Responses
Cancer Vaccines
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Ying Cao1,2, Wenlu Yan1,3, Wenzhe Yi1,3
1State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
生物工程系统通过提高疗效和安全性来增强抗瘤免疫疗法. 这些先进的平台提供精确的向,可控的治疗和降低毒性,以获得更好的癌症治疗结果.
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: